77 related articles for article (PubMed ID: 16809803)
1. Predictive power of an in vitro system to assess drug interactions of an antimuscarinic medication: a comparison of in vitro and in vivo drug-drug interaction studies of trospium chloride with digoxin.
Sandage B; Sabounjian L; Shipley J; Profy A; Lasseter K; Fox L; Harnett M
J Clin Pharmacol; 2006 Jul; 46(7):776-84. PubMed ID: 16809803
[TBL] [Abstract][Full Text] [Related]
2. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
[TBL] [Abstract][Full Text] [Related]
3. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein.
Keogh JP; Kunta JR
Eur J Pharm Sci; 2006 Apr; 27(5):543-54. PubMed ID: 16406207
[TBL] [Abstract][Full Text] [Related]
4. Trospium chloride treatment of overactive bladder.
Biastre K; Burnakis T
Ann Pharmacother; 2009 Feb; 43(2):283-95. PubMed ID: 19193592
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
Verstuyft C; Strabach S; El-Morabet H; Kerb R; Brinkmann U; Dubert L; Jaillon P; Funck-Brentano C; Trugnan G; Becquemont L
Clin Pharmacol Ther; 2003 Jan; 73(1):51-60. PubMed ID: 12545143
[TBL] [Abstract][Full Text] [Related]
6. Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.
Staskin D; Kay G; Tannenbaum C; Goldman HB; Bhashi K; Ling J; Oefelein MG
Int J Clin Pract; 2010 Aug; 64(9):1294-300. PubMed ID: 20561092
[TBL] [Abstract][Full Text] [Related]
7. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
[TBL] [Abstract][Full Text] [Related]
8. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
9. Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
Larsen UL; Hyldahl Olesen L; Guldborg Nyvold C; Eriksen J; Jakobsen P; Ăstergaard M; Autrup H; Andersen V
Scand J Clin Lab Invest; 2007; 67(2):123-34. PubMed ID: 17365992
[TBL] [Abstract][Full Text] [Related]
10. Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
Souza FC; Neri JS; Marques EB; Barros RB; Scaramello CB
Int J Cardiol; 2015 Jul; 191():4-6. PubMed ID: 25957928
[No Abstract] [Full Text] [Related]
11. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
Elsby R; Gillen M; Butters C; Imisson G; Sharma P; Smith V; Surry DD
Drug Metab Dispos; 2011 Feb; 39(2):275-82. PubMed ID: 21075975
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Drug-Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects.
Abebe BT; Weiss M; Modess C; Tadken T; Wegner D; Meyer MJ; Schwantes U; Neumeister C; Scheuch E; Schulz HU; Tzvetkov M; Siegmund W
J Clin Pharmacol; 2020 Mar; 60(3):312-323. PubMed ID: 31542894
[TBL] [Abstract][Full Text] [Related]
13. Absence of an interaction between tigecycline and digoxin in healthy men.
Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug.
Fenner KS; Troutman MD; Kempshall S; Cook JA; Ware JA; Smith DA; Lee CA
Clin Pharmacol Ther; 2009 Feb; 85(2):173-81. PubMed ID: 18987624
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
Verschraagen M; Koks CH; Schellens JH; Beijnen JH
Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
[TBL] [Abstract][Full Text] [Related]
17. Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers.
Ding R; Tayrouz Y; Riedel KD; Burhenne J; Weiss J; Mikus G; Haefeli WE
Clin Pharmacol Ther; 2004 Jul; 76(1):73-84. PubMed ID: 15229466
[TBL] [Abstract][Full Text] [Related]
18. Effects of the P-Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4-Way Crossover Drug-Drug Interaction Study in Healthy Subjects.
Abebe BT; Weiss M; Modess C; Roustom T; Tadken T; Wegner D; Schwantes U; Neumeister C; Schulz HU; Scheuch E; Siegmund W
J Clin Pharmacol; 2019 Oct; 59(10):1319-1330. PubMed ID: 30973998
[TBL] [Abstract][Full Text] [Related]
19. Absence of a clinically relevant interaction between etanercept and digoxin.
Zhou H; Parks V; Patat A; Le Coz F; Simcoe D; Korth-Bradley J
J Clin Pharmacol; 2004 Nov; 44(11):1244-51. PubMed ID: 15496642
[TBL] [Abstract][Full Text] [Related]
20. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
